Gastric cancer patients who underwent gastrectomy
Conditions
Interventions
An amount of 400ml/day of enteral nutritional supplement (Racol@ ) is administrated for patients with gastrectomy. This nutrition intervention is performed from postoperative day 2 today 90.
placebo g
Sponsors
Osaka University School of Medicine Gastroenterological Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) primary gastric cancer with preoperative diagnosis 2) planned surgical procedure: total, distal and proximal gastrectomy 3) R0 or R1 with CY positive in preoperative diagnosis 4) H0, P0 and M0 in preoperative diagnosis 5) Age>20 and <85 years 6) performance status: 0 to 2 (ECOG) 7) normal hepatic, renal and marrow function 8) possible to take orally 9) written informed consent
Exclusion criteria
Exclusion criteria: 1) with severe complication or active dual malignancy 2) judged as inappropriate by physician-in-charge 3) short-bowel syndrome 4) stenosed gut tract 5) past history of drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of change with weight in one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| five year overall survival, compliance of adjuvant S-1, muscle mass, muscle strength, body composition, compliance of enteral nutrient, postoperative complication rate, postoperative quality of life, clinical blood examination | — |
Countries
Japan
Contacts
Public ContactAtsushi Gakuhara
Osaka University School of Medicine Gastroenterological Surgery
Outcome results
None listed